Latest Period
n/a
Security Snapshot
Cellectar Biosciences, Inc. - Common Stock (CLRB) Institutional Ownership
CUSIP: 15117F500
13F Institutional Holders and Ownership History from Q2 2018 to Q2 2023
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- CLRB on Nasdaq
- Shares outstanding
- 8,719,970
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CLRB - Cellectar Biosciences, Inc. - Common Stock is tracked under CUSIP 15117F500.
- Latest finished 13F holder period is not available.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 1 to 0 between Q1 2023 and Q2 2023.
- SEC-reported value moved from $4 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
15117F500
Latest holder period
n/a
13F holders
13D/G owners
3
CIK / CUSIP context first
CLRB full holder history
Cellectar Biosciences, Inc. SEC filings
Cellectar Biosciences, Inc. company facts
Cellectar Biosciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 15117F500:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
CLRB
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 9.9% | 863,277 | Stonepine Capital Management, LLC | 04 May 2026 | ||||
| Rosalind Advisors, Inc. | 5.5% | -44% | 247,715 | -97% | Rosalind Advisors, Inc. | 31 Dec 2025 | ||
| ADAR1 Capital Management, LLC | 0.1% | 2,962 | ADAR1 Capital Management, LLC | 30 Jun 2025 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
20
Latest
n/a
Rows shown
1-20 of 20
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q2 | 0 | $0 | -$4 | 0 | |
| 2023 Q1 | 5 | $4 | +$4 | $0.80 | 1 |
| 2022 Q3 | 5 | $1,000 | -$1,914,000 | $200.00 | 1 |
| 2022 Q2 | 4,743,321 | $1,914,000 | -$711,862 | $0.40 | 24 |
| 2022 Q1 | 6,819,353 | $4,688,000 | +$178,821 | $0.69 | 27 |
| 2021 Q4 | 6,591,438 | $4,376,000 | -$753,116 | $0.66 | 35 |
| 2021 Q3 | 7,320,806 | $6,772,000 | -$6,047,136 | $0.92 | 36 |
| 2021 Q2 | 12,486,174 | $14,874,276 | -$4,685,208 | $1.19 | 42 |
| 2021 Q1 | 15,049,405 | $24,219,357 | -$5,794,482 | $1.61 | 42 |
| 2020 Q4 | 17,679,705 | $36,895,000 | +$23,156,825 | $2.08 | 38 |
| 2020 Q3 | 3,452,402 | $4,282,000 | +$542,449 | $1.24 | 19 |
| 2020 Q2 | 3,006,006 | $3,849,000 | +$1,971,582 | $1.28 | 21 |
| 2020 Q1 | 1,466,241 | $1,936,000 | +$222,918 | $1.31 | 15 |
| 2019 Q4 | 1,295,959 | $2,917,000 | -$498,988 | $2.25 | 9 |
| 2019 Q3 | 1,506,159 | $3,006,054 | -$985,030 | $2.00 | 12 |
| 2019 Q2 | 1,985,734 | $4,329,059 | +$3,787,212 | $2.18 | 11 |
| 2019 Q1 | 246,868 | $581,063 | -$32,864 | $2.35 | 9 |
| 2018 Q4 | 262,671 | $407,000 | +$89,332 | $1.55 | 9 |
| 2018 Q3 | 203,047 | $611,000 | +$567,000 | $3.01 | 9 |
| 2018 Q2 | 72,383 | $44,000 | +$44,000 | $0.61 | 1 |